Articles about 'Addenbrooke's Hospital'

A smart technology which involves smuggling gold nanoparticles into brain cancer cells has proven highly effective in lab-based tests.

Specialist hospital move will develop region's world-leading capabilities after £165 million deal approved

Researchers have identified 10 different types of the disease, laying groundwork for more effective, targeted treatment plans.

A collaborative project between physicists, oncologists and computer scientists at Oxford and Cambridge Universities, launched last month, will develop improved tools for the planning of high precision radiotherapy. Accel-RT will also help overcome time constraints that currently limit the use of complex radiotherapy treatment.

Technology developed at the University of Cambridge to detect peripheral visual field loss in young children will enable the earlier detection of brain tumours, potentially saving sight and lives.

Cambridge researchers are pioneering a new test for autism in the womb, by measuring the levels of testosterone produced by the foetus, which makes its way into the amniotic fluid. They hope to test if children who later develop autism have unusually high levels of testosterone between 12 and 20 weeks of pregnancy.

The Wolfson Brain Imaging Centre is a unique venture that brings together scientists and doctors from Cambridge University and Cambridge’s Addenbrookes Hospital for the development of new treatments for patients with brain disorders.

An international team of scientists, led by researchers based at the Cambridge Research Institute, have discovered a new mechanism that may explain why pancreatic cancer patients are often resistant to a common chemotherapy treatment, germcitabine.